UCSF Researchers Fingerprint Lung Tumors, Test New Drug Candidate
July 28th, 2006
Our own Dr. David Jablons made the LungBlog today. Adding their own contributions to a rapidly advancing field, UCSF researchers – along with colleagues from Incyte Corporation and the University of Texas Southwestern Medical Center – have described new targets in lung cancer and evaluated a promising new drug candidate that halts growth signals in tumor cells grown in the lab.